25.11新台幣0.27(1.09%)
2024/05/02更新
績效 / 1月0.59%
3月2.74%
1年8.84%
晨星評等 - 1.現金3.90%
- 2.股票23.73%
- 3.債券0.00%
- 4.其他72.37%
- 1.美國72.94%
- 2.歐洲不包含歐元區12.83%
- 3.英國8.11%
- 4.日本2.78%
- 1.Eli Lilly and Co9.41%
- 2.Regeneron Pharmaceuticals Inc8.51%
- 3.Vertex Pharmaceuticals Inc8.20%
- 4.Novo Nordisk A/S Class B7.96%
- 5.AstraZeneca PLC6.38%
- 6.Amgen Inc6.19%
- 7.Neurocrine Biosciences Inc4.22%
- 8.Gilead Sciences Inc4.19%
- 9.AbbVie Inc3.68%
- 10.Intuitive Surgical Inc2.98%
- 1.現金3.90%
- 2.股票23.73%
- 3.債券0.00%
- 4.其他72.37%
- 1.美國72.94%
- 2.歐洲不包含歐元區12.83%
- 3.英國8.11%
- 4.日本2.78%
- 1.Eli Lilly and Co9.41%
- 2.Regeneron Pharmaceuticals Inc8.51%
- 3.Vertex Pharmaceuticals Inc8.20%
- 4.Novo Nordisk A/S Class B7.96%
- 5.AstraZeneca PLC6.38%
- 6.Amgen Inc6.19%
- 7.Neurocrine Biosciences Inc4.22%
- 8.Gilead Sciences Inc4.19%
- 9.AbbVie Inc3.68%
- 10.Intuitive Surgical Inc2.98%